{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:23:17Z","timestamp":1771935797235,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Zinc Finger Protein 161 (ZFP161) is a key regulator of Ataxia Telangiectasia and Rad3-related (ATR) signaling, playing a crucial role in maintaining genomic stability. Human ZFP161 activates\n                    <jats:italic>c-MYC<\/jats:italic>\n                    , whereas its murine ortholog, ZF5, serves as a putative transcriptional repressor of\n                    <jats:italic>c-MYC<\/jats:italic>\n                    . In this study, we identified ZFP161 as a direct regulator of c-MYC. We show that ZFP161 binds to the promoter region of\n                    <jats:italic>c-MYC<\/jats:italic>\n                    , modulating its expression and downstream signaling pathways. Additionally, ZFP161 promotes cell proliferation and tumorigenesis through c-MYC regulation and contributes to the malignant transformation of non-cancerous retinal pigment epithelial (RPE-1) cells. Furthermore, high\n                    <jats:italic>ZFP161<\/jats:italic>\n                    expression is associated with poor survival in patients with mixed colon adenocarcinoma. These findings suggest that the regulation of\n                    <jats:italic>c-MYC<\/jats:italic>\n                    by ZFP161 may represent a potential therapeutic target in\n                    <jats:italic>c-MYC<\/jats:italic>\n                    -driven cancers.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2025.1680561","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:32:40Z","timestamp":1771392760000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC"],"prefix":"10.3389","volume":"15","author":[{"given":"Grania","family":"Christyani","sequence":"first","affiliation":[{"name":"Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University","place":["Cheonan, Chungcheongnam-do, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghui","family":"Cai","sequence":"additional","affiliation":[{"name":"College of Biology, Hunan University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yening","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic","place":["Rochester, MN, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyorin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University","place":["Cheonan, Chungcheongnam-do, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic","place":["Rochester, MN, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic","place":["Rochester, MN, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenkun","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic","place":["Rochester, MN, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wootae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University","place":["Cheonan, Chungcheongnam-do, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.02.75","article-title":"Cancer prevention from the perspective of global cancer burden patterns","volume":"9","author":"Nagai","year":"2017","journal-title":"J Thorac Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.582","article-title":"Oncogenes and tumor suppressor genes: functions and roles in cancers","volume":"5","author":"Dakal","year":"2020","journal-title":"MedComm"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071082","article-title":"Exploring the genetic orchestra of cancer: the interplay between oncogenes and tumor-suppressor genes","volume":"17","author":"Singh","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082296","article-title":"Transcription factors in cancer development and therapy","volume":"12","author":"Vishnoi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7150\/jca.1.136","article-title":"Functional mechanisms for human tumor suppressors","volume":"1","author":"Sun","year":"2010","journal-title":"J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2003.12.003","article-title":"DNA damage tumor suppressor genes and genomic instability","volume":"14","author":"Motoyama","year":"2004","journal-title":"Curr Opin Genet Dev"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6602918","article-title":"Epigenetics provides a new generation of oncogenes and tumour-suppressor genes","volume":"94","author":"Esteller","year":"2006","journal-title":"Br J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/wasj.2020.32","article-title":"Transcription factors and evolution: An integral part of gene expression (Review)","volume":"2","author":"Mitsis","year":"2020","journal-title":"World Acad Sci J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-021-00345-1","article-title":"Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma","volume":"10","author":"Li","year":"2022","journal-title":"biomark Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1997.4784","article-title":"The human gene ZFP161 on 18p11.21-pter encodes a putative c-myc repressor and is homologous to murine Zfp161 (Chr 17) and Zfp161-rs1 (X Chr)","volume":"43","author":"Sobek-Klocke","year":"1997","journal-title":"Genomics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1038\/s41467-019-13321-z","article-title":"ZFP161 regulates replication fork stability and maintenance of genomic stability by recruiting the ATR\/ATRIP complex","volume":"10","author":"Kim","year":"2019","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1415","article-title":"Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion","volume":"42","author":"Luisier","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/dgd.12431","article-title":"Coordinated regulation of the dorsal-ventral and anterior-posterior patterning of Xenopus embryos by the BTB\/POZ zinc finger protein Zbtb14","volume":"60","author":"Takebayashi-Suzuki","year":"2018","journal-title":"Dev Growth Differ"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/21.16.3767","article-title":"Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins","volume":"21","author":"Numoto","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.6.1108","article-title":"The ZiN\/POZ domain of ZF5 is required for both transcriptional activation and repression","volume":"25","author":"Kaplan","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14622","article-title":"Role of oncogenes and tumor-suppressor genes in carcinogenesis: A review","volume":"40","author":"Kontomanolis","year":"2020","journal-title":"Anticancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a014241","article-title":"MYC activation is a hallmark of cancer initiation and maintenance","volume":"4","author":"Gabay","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.it.2017.01.002","article-title":"MYC: master regulator of immune privilege","volume":"38","author":"Casey","year":"2017","journal-title":"Trends Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2014.03.013","article-title":"Myc and cell cycle control","volume":"1849","author":"Bretones","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/genes10030244","article-title":"MYC oncogene contributions to release of cell cycle brakes","volume":"10","author":"Garcia-Gutierrez","year":"2019","journal-title":"Genes (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/1947601910378025","article-title":"Myc regulation of mRNA cap methylation","volume":"1","author":"Cowling","year":"2010","journal-title":"Genes Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-Myc target genes involved in cell growth, apoptosis, and metabolism","volume":"19","author":"Dang","year":"1999","journal-title":"Mol Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","article-title":"Targeting oncogenic Myc as a strategy for cancer treatment","volume":"3","author":"Chen","year":"2018","journal-title":"Signal Transduct Target Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870401)59:7<1289::AID-CNCR2820590710>3.0.CO;2-O","article-title":"c-myc oncogene expression in colorectal cancer","volume":"59","author":"Sikora","year":"1987","journal-title":"Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature05674","article-title":"Myc deletion rescues Apc deficiency in the small intestine","volume":"446","author":"Sansom","year":"2007","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"He","year":"1998","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5710","DOI":"10.1038\/s41467-019-13651-y","article-title":"Examining multiple cellular pathways at once using multiplex hextuple luciferase assaying","volume":"10","author":"Sarrion-Perdigones","year":"2019","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2144\/04376RV01","article-title":"Chromatin immunoprecipitation assay","volume":"37","author":"Das","year":"2004","journal-title":"Biotechniques"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e37342","DOI":"10.1371\/journal.pone.0037342","article-title":"Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells","volume":"7","author":"Kuroda","year":"2012","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3791\/51998","article-title":"The soft agar colony formation assay","volume":"92","author":"Borowicz","year":"2014","journal-title":"J Vis Exp"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0872-9","article-title":"Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players","volume":"38","author":"Yuan","year":"2019","journal-title":"Oncogene"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-020-01291-6","article-title":"Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc","volume":"20","author":"Madden","year":"2021","journal-title":"Mol Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ng2047","article-title":"Tissue-specific transcriptional regulation has diverged significantly between human and mouse","volume":"39","author":"Odom","year":"2007","journal-title":"Nat Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27083","article-title":"Comparative analysis of human and mouse transcriptional cofactors (TcoFs) with special emphasis on intrinsically disordered regions and their associated regulating post-translational modifications","volume":"119","author":"Kamalesh D.","year":"2018","journal-title":"J Cell Biochem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1159\/000227619","article-title":"Overexpression and amplification of c-myc during progression of human colorectal cancer","volume":"53","author":"Rochlitz","year":"1996","journal-title":"Oncology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710366114","article-title":"Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC","volume":"114","author":"Satoh","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.15_suppl.11006","article-title":"Safety and activity of DCR-MYC, a first-in-class Dicer-substrate small interfering RNA (DsiRNA) targeting MYC, in a phase I study in patients with advanced solid tumors","volume":"33","author":"Tolcher","year":"2015","journal-title":"J Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02805-1","article-title":"MYC targeting by OMO-103 in solid tumors: a phase 1 trial","volume":"30","author":"Garralda","year":"2024","journal-title":"Nat Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1680561\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:30:25Z","timestamp":1771932625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1680561\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":49,"alternative-id":["10.3389\/fonc.2025.1680561"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1680561","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1680561"}}